Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019442408> ?p ?o ?g. }
- W2019442408 endingPage "593" @default.
- W2019442408 startingPage "573" @default.
- W2019442408 abstract "Among the FDA approved drugs for the treatment of AIDS, non-nucleoside reverse transcriptase inhibitors (NNRTIs) are essential components of first-line anti-HIV-1 therapy because of the less-severe adverse effects associated with NNRTIs administration in comparison to therapies based on other anti-HIV-1 agents. In this contest, 3,4-dihydro-2-alkoxy-6-benzyl-4-oxypyrimidines (DABOs) have been the object of many studies aimed at identifying novel analogues endowed with potent inhibitory activity towards HIV-1 wild type and especially drug-resistant mutants. Accordingly, based on the encouraging results obtained from the biological screening of our internal collection of S-DABO derivatives, we started with the systematic functionalization of the pyrimidine scaffold to identify the minimal required structural features for RT inhibition. Herein, we describe how the combination of synthetic, biological, and molecular modeling studies led to the identification of two novel subclasses of S-DABO analogues: S-DABO cytosine analogues (S-DABOCs) and 4-dimethyamino-6-vinylpyrimidines (DAVPs)." @default.
- W2019442408 created "2016-06-24" @default.
- W2019442408 creator A5000769645 @default.
- W2019442408 creator A5005793362 @default.
- W2019442408 creator A5006417481 @default.
- W2019442408 creator A5007630827 @default.
- W2019442408 creator A5010109904 @default.
- W2019442408 creator A5016372629 @default.
- W2019442408 creator A5043056449 @default.
- W2019442408 creator A5047141951 @default.
- W2019442408 creator A5048104582 @default.
- W2019442408 creator A5073481976 @default.
- W2019442408 creator A5076512137 @default.
- W2019442408 creator A5083359605 @default.
- W2019442408 creator A5084001430 @default.
- W2019442408 creator A5090204935 @default.
- W2019442408 date "2008-04-14" @default.
- W2019442408 modified "2023-10-18" @default.
- W2019442408 title "A Multidisciplinary Approach for the Identification of Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: S-DABOCs and DAVPs" @default.
- W2019442408 cites W1984814223 @default.
- W2019442408 cites W1985271914 @default.
- W2019442408 cites W1999577669 @default.
- W2019442408 cites W2002888071 @default.
- W2019442408 cites W2005610074 @default.
- W2019442408 cites W2022686380 @default.
- W2019442408 cites W2024912956 @default.
- W2019442408 cites W2038729300 @default.
- W2019442408 cites W2048320638 @default.
- W2019442408 cites W2055542167 @default.
- W2019442408 cites W2063381239 @default.
- W2019442408 cites W2065040389 @default.
- W2019442408 cites W2065197599 @default.
- W2019442408 cites W2066557443 @default.
- W2019442408 cites W2069066018 @default.
- W2019442408 cites W2070178355 @default.
- W2019442408 cites W2071313281 @default.
- W2019442408 cites W2084702672 @default.
- W2019442408 cites W2090810359 @default.
- W2019442408 cites W2092786021 @default.
- W2019442408 cites W2093668468 @default.
- W2019442408 cites W2102098015 @default.
- W2019442408 cites W2103766655 @default.
- W2019442408 cites W2109193129 @default.
- W2019442408 cites W2118865636 @default.
- W2019442408 cites W2124217674 @default.
- W2019442408 cites W2128508248 @default.
- W2019442408 cites W2131124255 @default.
- W2019442408 cites W2131371440 @default.
- W2019442408 cites W2133336323 @default.
- W2019442408 cites W2139617989 @default.
- W2019442408 cites W2142337547 @default.
- W2019442408 cites W2153193209 @default.
- W2019442408 cites W2175801090 @default.
- W2019442408 cites W2949576535 @default.
- W2019442408 cites W4243097513 @default.
- W2019442408 cites W2088916568 @default.
- W2019442408 doi "https://doi.org/10.1002/cmdc.200700198" @default.
- W2019442408 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18081133" @default.
- W2019442408 hasPublicationYear "2008" @default.
- W2019442408 type Work @default.
- W2019442408 sameAs 2019442408 @default.
- W2019442408 citedByCount "35" @default.
- W2019442408 countsByYear W20194424082012 @default.
- W2019442408 countsByYear W20194424082013 @default.
- W2019442408 countsByYear W20194424082014 @default.
- W2019442408 countsByYear W20194424082015 @default.
- W2019442408 countsByYear W20194424082016 @default.
- W2019442408 countsByYear W20194424082018 @default.
- W2019442408 countsByYear W20194424082019 @default.
- W2019442408 crossrefType "journal-article" @default.
- W2019442408 hasAuthorship W2019442408A5000769645 @default.
- W2019442408 hasAuthorship W2019442408A5005793362 @default.
- W2019442408 hasAuthorship W2019442408A5006417481 @default.
- W2019442408 hasAuthorship W2019442408A5007630827 @default.
- W2019442408 hasAuthorship W2019442408A5010109904 @default.
- W2019442408 hasAuthorship W2019442408A5016372629 @default.
- W2019442408 hasAuthorship W2019442408A5043056449 @default.
- W2019442408 hasAuthorship W2019442408A5047141951 @default.
- W2019442408 hasAuthorship W2019442408A5048104582 @default.
- W2019442408 hasAuthorship W2019442408A5073481976 @default.
- W2019442408 hasAuthorship W2019442408A5076512137 @default.
- W2019442408 hasAuthorship W2019442408A5083359605 @default.
- W2019442408 hasAuthorship W2019442408A5084001430 @default.
- W2019442408 hasAuthorship W2019442408A5090204935 @default.
- W2019442408 hasConcept C104317684 @default.
- W2019442408 hasConcept C156719811 @default.
- W2019442408 hasConcept C159047783 @default.
- W2019442408 hasConcept C185592680 @default.
- W2019442408 hasConcept C2776543447 @default.
- W2019442408 hasConcept C2909970146 @default.
- W2019442408 hasConcept C3013748606 @default.
- W2019442408 hasConcept C55493867 @default.
- W2019442408 hasConcept C67705224 @default.
- W2019442408 hasConcept C70721500 @default.
- W2019442408 hasConcept C71240020 @default.
- W2019442408 hasConcept C74187038 @default.
- W2019442408 hasConcept C86803240 @default.
- W2019442408 hasConceptScore W2019442408C104317684 @default.